Hello and welcome to the details of Swedish regulator asks doctors not to prescribe diabetes drugs for weight loss and now with the details
Nevin Al Sukari - Sana'a - World number one diabetes drug maker Novo Nordisk , and more recently also Eli Lily, are seeing demand soar for weight-loss drugs that are of a class originally designed to treat type 2 diabetes. — AFP pic
COPENHAGEN, Dec 11 — Sweden’s drugs agency today asked doctors to hold off on prescribing diabetes drugs for the treatment of obesity, pointing to signs that a spike in such usage has left diabetics short of medication.
World number one diabetes drug maker Novo Nordisk , and more recently also Eli Lily, are seeing demand soar for weight-loss drugs that are of a class originally designed to treat type 2 diabetes.
The so-called GLP-1 receptor agonists have also been shown to trigger a feeling of fullness after eating and slower gastric emptying.
The Swedish Medicines Agency said in a statement it urged doctors to prescribe specifically intended diabetes medicines only to patients diagnosed with the illness until further notice.
Advertisement
“The Swedish Medical Products Agency takes very seriously the fact that chronically ill patients are left without their medication due to an extensive prescription outside the approved indication,” it said.
There is a growing crisis in Europe over the supply of Novo Nordisk’s diabetes therapy Ozempic, which uses semaglutide, the same active ingredient as the drugmaker’s weight-loss drug Wegovy.
Physicians have the legal right to prescribe medicine for a purpose other than what the medicine is primarily intended for. — Reuters
Advertisement
These were the details of the news Swedish regulator asks doctors not to prescribe diabetes drugs for weight loss for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
